Evaluation of Antiplatelet Effects and Safety of Intraoperative Administration of Ticagrelor Versus Clopidogrel

NCT02513004 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Coronary Disease

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel

Sponsor

Yongjian Wu